Diagnostic CDMO Services
Developing high quality, resilient and scalable freeze dried and liquid formulations is vital for companies operating in the increasingly competitive global diagnostics industry. It is equally crucial that they launch these products to market as quickly and seamlessly as possible.
Biopharma Group provides a host of research and development (R&D), consultancy, and manufacturing services, which combine to enable you to swiftly produce robust and accurate products at scale. Through our versatile CDMO solutions, our expert scientific team can help you to reduce cold-chain logistics, optimise product performance, and extend the shelf life of your products.
Our end-to-end CDMO services support you throughout every step of your product’s development – from product assessment, proof of concept and formulation development to cycle development, troubleshooting, and scale up, technical transfer and manufacturing.
>> Read our Diagnostics CDMO Services Brochure
Why Choose Biopharma Group?
With over 35 years of freeze-drying experience, Biopharma Group is widely recognised as an industry leader in lyophilisation. Having completed over 4000+ projects across 30 countries, our team has the expertise, flexibility and capacity to meet your company’s specific requirements. Across these projects, our R&D services have delivered an average reduction of 80% in product storage costs for our customers, while decreasing their production costs by an average of 60%.
We were also a leading manufacturer of diagnostic tests for the UK’s National Health Service (NHS) throughout the COVID-19 pandemic. During which, we produced more than 2.5 million tests per month from 2020 to 2022.
By partnering with us, you can benefit from:
- Full intellectual property ownership (IP): Your organisation maintains full ownership of any products, processes, and IP created during the partnership. This provides you with complete autonomy over the project’s outputs and innovations, allowing you to implement these into your operations, audits, business strategy and brand identity.
- Assured compliance with IVDR: Our team has deep domain knowledge of in-vitro diagnostics for the point of care (PoC) sector. We provide expert advice and guidance on complying with the European Union’s In Vitro Diagnostics Regulation (IVDR), which is a required standard for all molecular diagnostics companies operating within the EU.
- Flexible production capacity: From one-off pilot-scale R&D work scopes to large-scale continuous production operations, our team has the agility and capacity to accommodate your project’s requirements.
- Secure worldwide shipping: We provide secure global shipping for all freeze-dried and liquid formulations. Our team can support a wide range of temperature levels – from -80°c to ambient temperatures.
- ISO accreditation: Biopharma Group is accredited to ISO 13485 and ISO 9001, ensuring full compliance with quality management regulations.
- Competitive pricing: Our CDMO diagnostics services are competitively priced, helping you to minimise your supply chain costs.
- Industry-leading innovation: Our scientific team was one of the industry’s leading innovators in lyobead technology. We continue to play an important role in evolving the technology to provide customers with accurate, fast, and cost-efficient lyobead generation services.


R&D / Analytical Services
- Process & Analytical Technology Services
- Analytical Lab Services
- Collaborative Research Services-up
- Specialist analytical services – FDM, DVS, SEM, XRD
- Consultancy and troubleshooting

Diagnostics Manufacturing
- Contract freeze drying for lyocakes
- Lyobeads technology
- Quality Control & ISO 13485 Compliance
- Packaging & kitting services
- Packing service for non-standard products